#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia refractory Cytomegalovirus infection Fusarium infection Anti-glomerular basement membrane disease Prodromal Alzheimer's disease Oropharyngeal squamous cell carcinoma Extra-osseous Ewing's sarcoma Hyperinsulinism Palmoplantar pustulosis Fragile X syndrome Renal disorder Polycystic liver disease Fibrous dysplasia of bone Neuroblastoma recurrent Type IIa hyperlipidaemia More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Treatment Basal cell naevus syndrome – Treatment Erdheim-Chester disease Biotinidase deficiency – Treatment Mastocytosis Glycogen storage disease type I – Life with Disease Alport’s syndrome – Basic Information Cytokine release syndrome – Treatment Mucopolysaccharidosis III Pulmonary fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MALIC ACID Ampicillin Sodium Oregovomab Pritelivir Alanyl Glutamine Ethanol, Anhydrous Ovolecithin Ecoo18A Brinzolamide Viltolarsen Munc-Cd34 Vamorolone Fludeoxyglucose (18F) Rifaximin Sodium Phosphate GRAPHITE Ecoo2 Mb-Cart20.1 Nvdx3 Neridronate Sodium More therapies…

    Learn about Your Condition

    Breast neoplasm Pouchitis Gestational diabetes Haemodynamic instability Giardiasis Coronary artery bypass Vertigo Colorectal cancer stage IV Acute myocardial infarction Cough Post-traumatic stress disorder Bipolar I disorder Adenocarcinoma Ocular myasthenia Diabetic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fibromyalgia

  • Study of rituximab for reducing pain in patients with fibromyalgia caused by autoantibodies

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Fibromyalgia
    Investigated Drugs:
    • Cetirizine Dihydrochloride
    • Methylprednisolone
    • Paracetamol
    Sweden
  • Study on Pain Relief for Fibromyalgia Patients with Trapezius Myofascial Syndrome Using Bupivacaine, Triamcinolone, and Sodium Chloride

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Fibromyalgia
    • Myofascial pain syndrome
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Triamcinolone Acetonide
    • Lidocaine Hydrochloride
    Spain
  • Study on Psilocybin’s Effect on Pain in Fibromyalgia Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Fibromyalgia
    Investigated Drugs:
    • Psilocybine
    The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!